title: Prostate cancer: Is active surveillance safe for obese patients?
authors.affiliation: Duke University, 571 Research Drive, MSRB 475, Durham, NC 27710, USA.
authors.forename: Stephen
authors.initials: S
authors.lastname: Freedland
authors.affiliation: Harvard School of Public Health, 677 Huntington Avenue, 9th Floor, Boston, MA 02115, USA.
authors.forename: Lorelei
authors.initials: L
authors.lastname: Mucci
mesh_terms: D001706:Biopsy; D051517:Digital Rectal Examination; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D009765:Obesity / Q000150:complications*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000150:complications* / Q000175:diagnosis*; D012306:Risk
chemical_list: D017430:Prostate-Specific Antigen
references.citation: Eur Urol. 2012 Nov;62(5):910-6
references.pmid: 22921964
references.citation: J Urol. 2014 Oct;192(4):1100-4
references.pmid: 24769031
references.citation: J Natl Cancer Inst. 1999 Mar 17;91(6):512-23
references.pmid: 10088621
references.citation: Cancer Prev Res (Phila). 2011 Apr;4(4):486-501
references.pmid: 21233290
references.citation: J Urol. 2010 Feb;183(2):629-33
references.pmid: 20018324
references.citation: J Natl Cancer Inst. 2012 Sep 5;104(17):1335-42
references.pmid: 22835388
references.citation: Lancet Oncol. 2008 Nov;9(11):1039-47
references.pmid: 18835745
references.citation: Cancer Prev Res (Phila). 2011 Apr;4(4):544-51
references.pmid: 21325564
references.citation: Eur Urol. 2014 Nov;66(5):841-8
references.pmid: 24954793
references.citation: Eur Urol. 2013 May;63(5):800-9
references.pmid: 23219374